Signet Investment Advisory Group Inc. reduced its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 2.1% in the 4th quarter, HoldingsChannel reports. The firm owned 4,029 shares of the company’s stock after selling 85 shares during the period. Signet Investment Advisory Group Inc.’s holdings in Clorox were worth $654,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of the business. Brooklyn Investment Group grew its holdings in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Carolina Wealth Advisors LLC purchased a new position in shares of Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial acquired a new stake in shares of Clorox in the third quarter valued at about $49,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CLX has been the topic of several recent analyst reports. JPMorgan Chase & Co. upped their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $158.21.
Clorox Trading Up 0.9 %
Shares of CLX stock opened at $148.47 on Wednesday. The company has a market capitalization of $18.38 billion, a price-to-earnings ratio of 40.56, a PEG ratio of 2.52 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The firm has a 50-day moving average price of $160.68 and a 200 day moving average price of $159.16. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm earned $2.16 earnings per share. Research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What is the MACD Indicator and How to Use it in Your Trading
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- How to buy stock: A step-by-step guide for beginnersÂ
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Stock Sentiment Analysis: How it Works
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.